BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32993278)

  • 1. Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer.
    Quhal F; Pradere B; Sari Motlagh R; Mori K; Laukhtina E; Aydh A; Mostafaei H; Lysenko I; Schuettfort VM; Stolzenbach F; Palumbo C; Heidenreich A; Briganti A; Karakiewicz PI; Chlosta P; Shariat SF
    Minerva Urol Nephrol; 2021 Oct; 73(5):610-615. PubMed ID: 32993278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy.
    Aydh A; Mori K; D'Andrea D; Motlagh RS; Abufaraj M; Pradere B; Mostafaei H; Laukhtina E; Quhal F; Karakiewicz PI; Luzzago S; Briganti A; Trinh QD; Parizi MK; Tilki D; Enikeev DV; Shariat SF
    Int J Clin Oncol; 2021 Sep; 26(9):1729-1735. PubMed ID: 34184136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
    Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
    Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy.
    Rajwa P; Schuettfort VM; Quhal F; Mori K; Katayama S; Laukhtina E; Pradere B; Motlagh RS; Mostafaei H; Grossmann NC; Aulitzky A; Paradysz A; Karakiewicz PI; Fajkovic H; Zimmermann K; Heidenreich A; Gontero P; Shariat SF
    World J Urol; 2021 Oct; 39(10):3771-3779. PubMed ID: 33997919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer.
    Chung JW; Ha YS; Kim SW; Park SC; Kang TW; Jeong YB; Park SW; Park J; Yoo ES; Kwon TG; Seo SP; Kang HW; Kim WT; Kim YJ; Lee SC; Kim WJ; Yun SJ; Kim TH
    Investig Clin Urol; 2021 Sep; 62(5):545-552. PubMed ID: 34387034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer.
    Mari A; Abufaraj M; Foerster B; Özsoy M; Briganti A; Rouprêt M; Karakiewicz PI; Mathieu R; D'Andrea D; Chade DC; Shariat SF
    Clin Genitourin Cancer; 2018 Jun; 16(3):e619-e627. PubMed ID: 29239845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy.
    Quhal F; Abufaraj M; Janisch F; Mori K; Lysenko I; Mostafaei H; D'Andrea D; Mathieu R; Enikeev DV; Fajkovic H; Heidenreich A; Shariat SF
    Arab J Urol; 2020 May; 18(4):213-218. PubMed ID: 33312731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
    Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
    World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: "Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer".
    Sciarra A; Maggi M
    Minerva Urol Nephrol; 2021 Oct; 73(5):683-685. PubMed ID: 34847653
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
    Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
    Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis.
    Liu Z; Huang H; Li S; Yu W; Li W; Jin J; Li X; Xing J
    J Cancer Res Ther; 2017; 13(5):837-843. PubMed ID: 29237914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serum cholinesterase in patients treated with salvage radical prostatectomy.
    Vartolomei MD; D'Andrea D; Chade DC; Soria F; Kimura S; Foerster B; Abufaraj M; Mathieu R; Moschini M; Rouprêt M; Briganti A; Karakiewicz PI; Shariat SF
    Urol Oncol; 2019 Feb; 37(2):123-129. PubMed ID: 30522902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review.
    Salciccia S; Frisenda M; Bevilacqua G; Viscuso P; Casale P; De Berardinis E; Di Pierro GB; Cattarino S; Giorgino G; Rosati D; Del Giudice F; Sciarra A; Mariotti G; Gentilucci A
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Preoperative Serum Albumin-Globulin Ratio and Prognosis of Patients Undergoing Low Rectal Cancer Surgery.
    Rong G; Liu S; Xi C; Wang C; Deng J; Qin T
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
    Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
    BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Heidenreich A; Richter S; Thüer D; Pfister D
    Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
    Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
    Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.
    Marra G; Karnes RJ; Calleris G; Oderda M; Alessio P; Palazzetti A; Battaglia A; Pisano F; Munegato S; Munoz F; Filippini C; Ricardi U; Linares E; Sanchez-Salas R; Goonewardene S; Dasgupta P; Challacombe B; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Smelzo S; Piechaud T; Taille A; Roupret M; Albisinni S; van Velthoven R; Morlacco A; Vidit S; Gandaglia G; Mottrie A; Smith J; Joshi S; Fiscus G; Berger A; Aron M; Abreu A; Gill IS; Van Der Poel H; Tilki D; Murphy D; Lawrentschuk N; Davis J; Gontero P
    Urol Oncol; 2021 May; 39(5):296.e21-296.e29. PubMed ID: 33436329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.